Regulation of tumor angiogenesis by dietary fatty acids and eicosanoids - PubMed (original) (raw)

Review

Regulation of tumor angiogenesis by dietary fatty acids and eicosanoids

D P Rose et al. Nutr Cancer. 2000.

Abstract

Angiogenesis is a prerequisite for tumor growth and metastasis. Vascular endothelial cell proliferation, migration, and capillary formation are stimulated by angiogenic growth factors, which include the proteins vascular endothelial growth factor, basic fibroblast growth factor, and transforming growth factor-beta, and eicosanoids synthesized from n-6 fatty acids. Clinical studies have shown that angiogenesis in solid tumors relates to a poor prognosis and, in premalignant lesions, indicates potential for cancerous transformation. High-fat, n-6 fatty acid-rich diets were associated with a relatively poor prognosis in breast cancer patients; in a nude mouse model the same diet enhanced breast cancer progression, whereas n-3 fatty acids exerted suppressive effects that were associated with impaired angiogenesis. Lipoxygenase and cyclooxygenase products of n-6 fatty acid metabolism are angiogenic in in vitro assays. This activity is blocked by pharmacological inhibitors of eicosanoid biosynthesis, and one, indomethacin, suppressed n-6 fatty acid-stimulated murine mammary carcinoma growth and metastasis and tumor vascularization. Review of the experimental data suggests that selective inhibitors of eicosanoid-synthesizing enzymes and dietary intervention with n-3 fatty acids merit clinical evaluation as adjuvant therapy and chemopreventive agents.

PubMed Disclaimer

Similar articles

• Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
  Sawaoka H, Tsuji S, Tsujii M, Gunawan ES, Sasaki Y, Kawano S, Hori M. Sawaoka H, et al. Lab Invest. 1999 Dec;79(12):1469-77. Lab Invest. 1999. PMID: 10616198
• PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
  Wood JM, Bold G, Buchdunger E, Cozens R, Ferrari S, Frei J, Hofmann F, Mestan J, Mett H, O'Reilly T, Persohn E, Rösel J, Schnell C, Stover D, Theuer A, Towbin H, Wenger F, Woods-Cook K, Menrad A, Siemeister G, Schirner M, Thierauch KH, Schneider MR, Drevs J, Martiny-Baron G, Totzke F. Wood JM, et al. Cancer Res. 2000 Apr 15;60(8):2178-89. Cancer Res. 2000. PMID: 10786682
• [Dietary fatty acids and experimental carcinogenesis].
  Bougnoux P, Menanteau J. Bougnoux P, et al. Bull Cancer. 2005 Jul;92(7):685-96. Bull Cancer. 2005. PMID: 16123007 Review. French.
• Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
  Wood JM. Wood JM. Medicina (B Aires). 2000;60 Suppl 2:41-7. Medicina (B Aires). 2000. PMID: 11188930
• Regulators of angiogenesis as targets for anti-angiogenic tumor therapy.
  Breier G, Heidenreich R, Gaumann A, Groot M, Licht A, Nicolaus A, Schmitz J, Reichmann E, Plate KH, Vajkoczy P. Breier G, et al. Ann Hematol. 2002;81 Suppl 2:S71-2. Ann Hematol. 2002. PMID: 12611084 Review. No abstract available.

Cited by

• CD36 inhibition reduces non-small-cell lung cancer development through AKT-mTOR pathway.
  Liu H, Guo W, Wang T, Cao P, Zou T, Peng Y, Yan T, Liao C, Li Q, Duan Y, Han J, Zhang B, Chen Y, Zhao D, Yang X. Liu H, et al. Cell Biol Toxicol. 2024 Feb 6;40(1):10. doi: 10.1007/s10565-024-09848-7. Cell Biol Toxicol. 2024. PMID: 38319449 Free PMC article.
• Diet, Sports, and Psychological Stress as Modulators of Breast Cancer Risk: Focus on OPRM1 Methylation.
  Li L, Li S, Qin S, Gao Y, Wang C, Du J, Zhang N, Chen Y, Han Z, Yu Y, Wang F, Zhao Y. Li L, et al. Front Nutr. 2021 Dec 8;8:747964. doi: 10.3389/fnut.2021.747964. eCollection 2021. Front Nutr. 2021. PMID: 35024367 Free PMC article.
• Her-2 Breast Cancer Outcomes Are Mitigated by Consuming n-3 Polyunsaturated, Saturated, and Monounsaturated Fatty Acids Compared to n-6 Polyunsaturated Fatty Acids.
  Hillyer LM, Hucik B, Baracuhy EM, Lin Z, Muller WJ, Robinson LE, Ma DWL. Hillyer LM, et al. Nutrients. 2020 Dec 20;12(12):3901. doi: 10.3390/nu12123901. Nutrients. 2020. PMID: 33419361 Free PMC article.
• Dietary Constituents: Relationship with Breast Cancer Prognostic (MCC-SPAIN Follow-Up).
  Dierssen-Sotos T, Gómez-Acebo I, Gutiérrez-Ruiz N, Aragonés N, Amiano P, Molina de la Torre AJ, Guevara M, Alonso-Molero J, Obon-Santacana M, Fernández-Tardón G, Molina-Barceló A, Alguacil J, Marcos-Gragera R, Rodríguez-Cundín P, Castaño-Vinyals G, Canseco Fernandez R, Castilla J, Molinuevo A, Pérez-Gómez B, Kogevinas M, Pollán M, Llorca J. Dierssen-Sotos T, et al. Int J Environ Res Public Health. 2020 Dec 24;18(1):84. doi: 10.3390/ijerph18010084. Int J Environ Res Public Health. 2020. PMID: 33374289 Free PMC article.
• Implications of dietary ω-3 and ω-6 polyunsaturated fatty acids in breast cancer.
  Zanoaga O, Jurj A, Raduly L, Cojocneanu-Petric R, Fuentes-Mattei E, Wu O, Braicu C, Gherman CD, Berindan-Neagoe I. Zanoaga O, et al. Exp Ther Med. 2018 Feb;15(2):1167-1176. doi: 10.3892/etm.2017.5515. Epub 2017 Nov 16. Exp Ther Med. 2018. PMID: 29434704 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Taylor & Francis

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information